VDEC rapidly develops an immunoassay for Mpox during the 2022 global outbreak

image_pdfimage_print

To better understand Mpox and its spread within the UK, VDEC developed an immunoassay to assess immune responses to Mpox infection and new vaccines.

Leave a Reply

Your email address will not be published.